Cancer cells are masters at avoiding detection, but a new system developed by Yale scientists can make them stand out from the crowd and help the immune system spot and eliminate tumors that other forms of immunotherapies might miss, the researchers...
Many neurodevelopmental disorders such as epilepsy, schizophrenia, and autism have been linked to disruption of the key neurotransmitter GABA, but the underlying causes of the disruptions have been difficult to pinpoint. In two new papers published Oct....
The National Institutes of Health (NIH) through the Rare Diseases Clinical Research Consortia (RDCRC) has awarded a research team from Yale University, George Washington University, and Duke University $7.8 million to establish a rare disease network for...
Adult populations in the Caribbean, mirroring black populations in the U.S., experience higher rates of hypertension, stroke, and heart disease, and researchers want to know why.
Among them is Yale School of Medicine researcher and physician Dr. Erica...
Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment. The work is described in a study published...
Six Yale faculty members have been elected to the National Academy of Medicine (NAM), the organization announced Oct. 21 at its annual meeting.
The six faculty are among 100 new members elected by the organization to receive the honor, which recognizes...